Trials / Completed
CompletedNCT00062790
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels
Effects of Dutasteride on Intraprostatic Dihydrotestosterone (DHT) Levels
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Male
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to determine how much certain hormone levels in the prostate decrease when a patient takes dutasteride 0.5mg daily for 3 months prior to TURP. Male patients at least 50 years old willing to take either dutasteride or a placebo (dummy pill) once daily by mouth for 3 months prior to having a surgery to reduce the size of their prostate. During the surgery, very small pieces of the prostate that are removed will be tested to see how much dihydrotestosterone and testosterone (male hormones) are in the tissue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dutasteride |
Timeline
- Start date
- 2003-10-01
- Completion
- 2005-07-01
- First posted
- 2003-06-17
- Last updated
- 2016-09-15
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00062790. Inclusion in this directory is not an endorsement.